Unit:
|
Changle
|
|
Project Area:
|
Fuzhou-changle Jinbin Road, Wenwu Sha Street, Changle District, Fuzhou
|
|
Industry:
|
Electronic Information and Digital Industry,Advanced Equipment Manufacturing Industry,Biological and New Pharmaceutical Industry
|
|
Type of Project:
|
New Project
|
|
Cooperation Mode:
|
Joint Venture,Collaborate
|
|
Nature of Project:
|
Encourage
|
|
Working Progress in Prior Period:
|
completed
|
|
Total Investment:
|
67950 ten thousand RMB
|
|
Expected to Attract Investment:
|
67950 ten thousand RMB
|
Electronic Information and Digital Industry
In 2020, output of industrial companies with annual revenue of more than RMB 20 million expanded by 6.6 percent year-on-year, exceeding RMB 800 billion. Xiamen City and Fuzhou City are the main production bases for computers and new displays in the province. Fujian has become one of the main production bases of terminal products such as flat panel displays, laptops, and LCD TVs in China, and one of China’s strongest and largest production bases for LED epitaxial wafers with the most complete varieties.
Advanced Equipment Manufacturing Industry
In 2020, the output of industrial companies with annual revenue of more than RMB 20 million increased by 1.1 percent year on year, exceeding RMB 870 billion. The production and sale of loaders, medium and large-sized buses, automobile steel wheels, joint bearings, road rollers, and small and medium-sized electrical machinery are at the forefront of advanced equipment manufacturing growth in China.
Biological & New Pharmaceutical Industry
In 2020, the added value of industrial enterprises above designated size rose by 0.3 percent year on year, and the output value of the industry exceeded RMB 60 billion. The technology of such protein drugs as recombinant human granulocyte-macrophage colony-stimulating factor and its market share took the lead in China. In addition, bio-pharmaceutical technologies such as an Escherichia coli-derived virus-like particle-based vaccine, a recombinant hepatitis E vaccine, and a recombinant human papillomavirus vaccine all held world leading positions.